Acasă › Cancer pulmonar cu celule non-pătrate › Washington › Tacoma
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Tacoma, WA
20 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Tacoma (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
În curs de recrutareFaza 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · La 26 mi distanță
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
În curs de recrutareFaza 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · La 8 mi distanță
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · La 8 mi distanță
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- American Oncology Network Vista Oncology Division-West office, Olympia · La 26 mi distanță
- American Oncology Network Vista Oncology Division-East office, Olympia · La 26 mi distanță
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
În curs de recrutareFaza 3
- Vista Oncology Inc PS, Olympia · La 26 mi distanță
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Vista Oncology, Olympia · La 26 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- American Oncology Network Vista Oncology Division-West office, Olympia · La 26 mi distanță
- American Oncology Network Vista Oncology Division-East office, Olympia · La 26 mi distanță
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
În curs de recrutareFaza 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
În curs de recrutareStudiu observațional
- Northwest Medical Specialties (NWMS), Tacoma
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
În curs de recrutareFaza 3
- Local Institution - 0499, Lacey · La 23 mi distanță
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Research Site, Tacoma
- Research Site, Olympia · La 26 mi distanță
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · La 26 mi distanță
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
În curs de recrutareFaza 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
În curs de recrutareFaza 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · La 8 mi distanță
- și încă 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
În curs de recrutareFaza 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · La 8 mi distanță
- MultiCare Regional Cancer Center, Puyallup · La 8 mi distanță
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 2
- USA09-0, Puyallup · La 8 mi distanță
BostonGene and Exigent Genomic INsight Study
În curs de recrutareStudiu observațional
- Northwest Medical Specialities, Puyallup · La 8 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Tacoma
- Cancer de sân18 studii
- Colită ulcerativă15 studii
- Mielom multiplu13 studii
- Cancer de prostată11 studii
- Boala Crohn11 studii
- Cancer colorectal9 studii
- Cancer metastatic9 studii
- Melanom7 studii
- Cancer ovarian7 studii
- Cancer gastric6 studii
- Cancer esofagian6 studii
- Cancer (toate tipurile)6 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.